-+ 0.00%
-+ 0.00%
-+ 0.00%

Artelo Biosciences Q1 EPS $(4.00) Misses $(1.57) Estimate

Benzinga·05/14/2026 20:56:36
Listen to the news
Artelo Biosciences (NASDAQ:ARTL) reported quarterly losses of $(4.00) per share which missed the analyst consensus estimate of $(1.57) by 154.78 percent. This is a 69.14 percent increase over losses of $(12.96) per share from the same period last year.